metoprolol has been researched along with Coronary Artery Disease in 44 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to evaluate the efficacy and safety of fixed-dose combination (FDC) of metoprolol, telmisartan, and chlorthalidone in patients with essential hypertension and stable coronary artery disease (CAD) who showed inadequate response to dual therapy." | 9.51 | Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study. ( Agrawal, S; Anand, J; Bachani, D; Doshi, M; Gaikwad, VB; Halder, SK; Kinholkar, B; Kumar, DA; Kumbhar, A; Mathur, R; Mehta, S; Sarkar, G; Sharma, A, 2022) |
| "To explore possible differential effects between metoprolol and atenolol in patients with coronary artery disease." | 9.16 | Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease. ( Aaberge, L; Ablad, B; Bjurö, T; Gullestad, L; Høglund, L; Kjekshus, E; Mellgård, AJ; Pernow, J; Skårdal, R; Wahlquist, I, 2012) |
| "To assess the effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease (CAD) who were to undergo non-cardiac surgery." | 9.13 | [Effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease undergoing non-cardiac surgery]. ( Wang, Q; Wang, S; Wu, XM; Yang, XY, 2008) |
| "A systematic review and meta-analysis was performed to evaluate the effects of carvedilol versus metoprolol on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting in randomized controlled trials." | 8.90 | Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting. ( Aradi, D; Beavers, CJ; Biondi-Zoccai, G; Brugts, J; Chatterjee, S; D'Ascenzo, F; DiNicolantonio, JJ; Gasparini, M; Komócsi, A; Lavie, CJ; Meier, P; Menezes, AR; O'Keefe, JH; Vorobcsuk, A, 2014) |
| " A patient suffering from coronary artery disease and taking metoprolol and aspirin was stung by wasps and developed cutaneous allergic signs including rash, urticaria and orbital oedema." | 7.74 | Hymenoptera sting-induced Kounis syndrome: effects of aspirin and beta-blocker administration. ( Ioannidis, TI; Karpeta, MZ; Kounis, GN; Kounis, NG; Mazarakis, A; Notaras, SP; Rallis, DG; Tsintoni, AC, 2007) |
| "Emergency physicians should bear in mind that AMI can accompany the presentation of metoprolol overdose in those with coronary artery disease." | 7.74 | Cardiovascular toxicity due to metoprolol poisoning in a patient with coronary artery disease. ( Bozkurt, S; Kaynak, F; Topacoglu, H; Unverir, P, 2007) |
| "We studied the value of a rapid beta-blocker injection at peak dobutamine-atropine stress echocardiography (DASE) for the detection of coronary artery disease (CAD)." | 7.72 | Value of rapid beta-blocker injection at peak dobutamine-atropine stress echocardiography for detection of coronary artery disease. ( Andrade, JL; Khandheria, BK; Kowatsch, I; Leal, SM; Lemos, PA; Mathias, W; Ramires, JF; Tsutsui, JM, 2003) |
| "The aim of the study was to evaluate the efficacy and safety of fixed-dose combination (FDC) of metoprolol, telmisartan, and chlorthalidone in patients with essential hypertension and stable coronary artery disease (CAD) who showed inadequate response to dual therapy." | 5.51 | Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study. ( Agrawal, S; Anand, J; Bachani, D; Doshi, M; Gaikwad, VB; Halder, SK; Kinholkar, B; Kumar, DA; Kumbhar, A; Mathur, R; Mehta, S; Sarkar, G; Sharma, A, 2022) |
| " No adverse event was experienced." | 5.32 | Metoprolol, a beta-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease. ( Akkuş, N; Alkan, M; Arikan, S; Avan, C; Aydoğdu, S; Camsari, A; Ciçek, D; Kaya, D; Kiykim, A; Pekdemir, H; Sezer, K, 2003) |
| "To explore possible differential effects between metoprolol and atenolol in patients with coronary artery disease." | 5.16 | Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease. ( Aaberge, L; Ablad, B; Bjurö, T; Gullestad, L; Høglund, L; Kjekshus, E; Mellgård, AJ; Pernow, J; Skårdal, R; Wahlquist, I, 2012) |
| "To assess the effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease (CAD) who were to undergo non-cardiac surgery." | 5.13 | [Effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease undergoing non-cardiac surgery]. ( Wang, Q; Wang, S; Wu, XM; Yang, XY, 2008) |
| "In the Angina Prognosis Study in Stockholm (APSIS), 809 patients with stable angina pectoris were studied prospectively during double-blind treatment with verapamil or metoprolol." | 5.09 | Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. ( Björkander, I; Eriksson, SV; Forslund, L; Held, C; Hjemdahl, P; Rehnqvist, N, 2001) |
| "A systematic review and meta-analysis was performed to evaluate the effects of carvedilol versus metoprolol on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting in randomized controlled trials." | 4.90 | Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting. ( Aradi, D; Beavers, CJ; Biondi-Zoccai, G; Brugts, J; Chatterjee, S; D'Ascenzo, F; DiNicolantonio, JJ; Gasparini, M; Komócsi, A; Lavie, CJ; Meier, P; Menezes, AR; O'Keefe, JH; Vorobcsuk, A, 2014) |
| " A patient suffering from coronary artery disease and taking metoprolol and aspirin was stung by wasps and developed cutaneous allergic signs including rash, urticaria and orbital oedema." | 3.74 | Hymenoptera sting-induced Kounis syndrome: effects of aspirin and beta-blocker administration. ( Ioannidis, TI; Karpeta, MZ; Kounis, GN; Kounis, NG; Mazarakis, A; Notaras, SP; Rallis, DG; Tsintoni, AC, 2007) |
| "Emergency physicians should bear in mind that AMI can accompany the presentation of metoprolol overdose in those with coronary artery disease." | 3.74 | Cardiovascular toxicity due to metoprolol poisoning in a patient with coronary artery disease. ( Bozkurt, S; Kaynak, F; Topacoglu, H; Unverir, P, 2007) |
| "We studied the value of a rapid beta-blocker injection at peak dobutamine-atropine stress echocardiography (DASE) for the detection of coronary artery disease (CAD)." | 3.72 | Value of rapid beta-blocker injection at peak dobutamine-atropine stress echocardiography for detection of coronary artery disease. ( Andrade, JL; Khandheria, BK; Kowatsch, I; Leal, SM; Lemos, PA; Mathias, W; Ramires, JF; Tsutsui, JM, 2003) |
| "Ivabradine is a selective HR-lowering agent that exclusively inhibits the I(f) current in sinoatrial node cells without having any effect on cardiac contractility or atrioventricular conduction." | 2.77 | Ivabradine versus metoprolol for heart rate reduction before coronary computed tomography angiography. ( Dock, W; Mendel, H; Pichler, P; Pichler-Cetin, E; Sochor, H; Syeda, B; Vertesich, M, 2012) |
| "Ivabradine is a selective inhibitor of the I(f) current, which primarily contributes to sinus node pacemaker activity, and has no significant direct cardiovascular effects such as reduction of blood pressure, cardiac contractility or impairment of cardiac conduction." | 2.77 | Safety and efficacy of oral ivabradine as a heart rate-reducing agent in patients undergoing CT coronary angiography. ( Adile, KK; Garg, N; Goel, PK; Gupta, A; Jain, SK; Kapoor, A; Kumar, S; Tewari, S, 2012) |
| "Provide a safe and efficient metoprolol dose protocol to be used in pediatric outpatients undergoing CCTA." | 1.62 | Safety, Efficacy, and Dose Protocol of Metoprolol for Heart Rate Reduction in Pediatric Outpatients Undergoing Cardiac CT Angiography. ( Casey, SA; Caye, DJ; Han, BK; J Chu, B; Lesser, JR; Lindberg, BJ; Nunes, MO; Stanberry, LI; Witt, DR, 2021) |
| " No adverse event was experienced." | 1.32 | Metoprolol, a beta-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease. ( Akkuş, N; Alkan, M; Arikan, S; Avan, C; Aydoğdu, S; Camsari, A; Ciçek, D; Kaya, D; Kiykim, A; Pekdemir, H; Sezer, K, 2003) |
| "Metoprolol treatment led to a substantial elevation of the plasma triacylglycerol level and, with time, a reduced cholesterolemic response." | 1.28 | Effects of diet and metoprolol on lipid levels in the blood plasma and morphology of the heart and intramural branches of coronary arteries of spontaneously hypertensive male rats. A 9-month study. ( Eklund, A; Jönsson, L; Ostlund-Lindqvist, AM; Sjöblom, L, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (6.82) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 25 (56.82) | 29.6817 |
| 2010's | 12 (27.27) | 24.3611 |
| 2020's | 4 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Sarkar, G | 1 |
| Gaikwad, VB | 1 |
| Sharma, A | 1 |
| Halder, SK | 1 |
| Kumar, DA | 1 |
| Anand, J | 1 |
| Agrawal, S | 1 |
| Kumbhar, A | 1 |
| Kinholkar, B | 1 |
| Mathur, R | 1 |
| Doshi, M | 1 |
| Bachani, D | 1 |
| Mehta, S | 1 |
| Androshchuk, V | 1 |
| Sabharwal, N | 1 |
| St Noble, V | 1 |
| Kelion, A | 1 |
| Nunes, MO | 1 |
| Witt, DR | 1 |
| Casey, SA | 1 |
| Stanberry, LI | 1 |
| Caye, DJ | 1 |
| J Chu, B | 1 |
| Lindberg, BJ | 1 |
| Lesser, JR | 1 |
| Han, BK | 1 |
| Vimala, LR | 1 |
| Eifer, DA | 1 |
| Karimzad, Y | 1 |
| Paul, NS | 1 |
| Katsi, V | 1 |
| Skalis, G | 1 |
| Kallistratos, MS | 1 |
| Tsioufis, K | 1 |
| Makris, T | 1 |
| Manolis, AJ | 1 |
| Tousoulis, D | 1 |
| Celik, O | 1 |
| Atasoy, MM | 1 |
| Ertürk, M | 1 |
| Yalçın, AA | 1 |
| Aksu, HU | 1 |
| Diker, M | 1 |
| Aktürk, IF | 1 |
| Atasoy, I | 1 |
| DiNicolantonio, JJ | 1 |
| Beavers, CJ | 1 |
| Menezes, AR | 1 |
| Lavie, CJ | 1 |
| O'Keefe, JH | 1 |
| Meier, P | 1 |
| Vorobcsuk, A | 1 |
| Aradi, D | 1 |
| Komócsi, A | 1 |
| Chatterjee, S | 1 |
| D'Ascenzo, F | 1 |
| Gasparini, M | 1 |
| Brugts, J | 1 |
| Biondi-Zoccai, G | 1 |
| Ignjatovic, V | 1 |
| Pavlovic, S | 1 |
| Miloradovic, V | 1 |
| Andjelkovic, N | 1 |
| Davidovic, G | 1 |
| Djurdjevic, P | 1 |
| Stolic, R | 1 |
| Iric-Cupic, V | 1 |
| Simic, I | 1 |
| Ignjatovic, VD | 1 |
| Petrovic, N | 1 |
| Smiljanic, Z | 1 |
| Zdravkovic, V | 1 |
| Simovic, S | 1 |
| Jovanovic, D | 1 |
| Nesic, J | 1 |
| Suh, YJ | 1 |
| Hong, YJ | 1 |
| Lee, HJ | 1 |
| Hur, J | 1 |
| Kim, YJ | 2 |
| Lee, HS | 1 |
| Hong, SR | 1 |
| Im, DJ | 1 |
| Park, CH | 1 |
| Kim, TH | 1 |
| Yoo, KJ | 1 |
| Choi, BW | 1 |
| Aldemir, M | 1 |
| Keleş, İ | 1 |
| Karalar, M | 1 |
| Tecer, E | 1 |
| Adalı, F | 1 |
| Pektaş, MB | 1 |
| Parlar, Aİ | 1 |
| Darçın, OT | 1 |
| Li, D | 1 |
| Dong, W | 1 |
| Chen, Y | 1 |
| Xu, Y | 1 |
| Zhou, H | 1 |
| Wang, M | 1 |
| Tang, Q | 1 |
| Lü, S | 1 |
| Wang, Y | 1 |
| Chen, H | 1 |
| Karapandzic, VM | 1 |
| Vujisic-Tesic, BD | 1 |
| Pesko, PM | 1 |
| Nenadic, BM | 1 |
| Babic, DD | 1 |
| Yang, XY | 1 |
| Wu, XM | 1 |
| Wang, S | 1 |
| Wang, Q | 1 |
| Canbay, A | 1 |
| Ozcan, O | 1 |
| Demir, M | 1 |
| Ozaydin, M | 1 |
| Varol, E | 1 |
| Doğan, A | 1 |
| Altinbaş, A | 1 |
| Björkander, I | 2 |
| Forslund, L | 2 |
| Ericson, M | 1 |
| Rehnqvist, N | 2 |
| Hjemdahl, P | 2 |
| Kahan, T | 1 |
| Allen LaPointe, NM | 1 |
| Zhou, Y | 1 |
| Stafford, JA | 1 |
| Hernandez, AF | 1 |
| Kramer, JM | 1 |
| Anstrom, KJ | 1 |
| McNeely, M | 1 |
| Connelly, NR | 1 |
| Arslan, S | 1 |
| Gurlertop, Y | 1 |
| Elbey, MA | 1 |
| Karakelleoglu, S | 1 |
| Avci, E | 1 |
| Yeşil, M | 1 |
| Bayata, S | 1 |
| Postaci, N | 1 |
| Arikan, E | 1 |
| Cirit, M | 1 |
| Pichler, P | 1 |
| Pichler-Cetin, E | 1 |
| Vertesich, M | 1 |
| Mendel, H | 1 |
| Sochor, H | 1 |
| Dock, W | 1 |
| Syeda, B | 1 |
| Gullestad, L | 1 |
| Pernow, J | 1 |
| Bjurö, T | 1 |
| Aaberge, L | 1 |
| Skårdal, R | 1 |
| Kjekshus, E | 1 |
| Høglund, L | 1 |
| Mellgård, AJ | 1 |
| Wahlquist, I | 1 |
| Ablad, B | 1 |
| Adile, KK | 1 |
| Kapoor, A | 1 |
| Jain, SK | 1 |
| Gupta, A | 1 |
| Kumar, S | 1 |
| Tewari, S | 1 |
| Garg, N | 1 |
| Goel, PK | 1 |
| Cotarlan, V | 1 |
| Brofferio, A | 1 |
| Gerhard, GS | 1 |
| Chu, X | 1 |
| Shirani, J | 1 |
| Rau, T | 1 |
| Heide, R | 1 |
| Bergmann, K | 1 |
| Wuttke, H | 1 |
| Werner, U | 1 |
| Feifel, N | 1 |
| Eschenhagen, T | 1 |
| Armanious, S | 1 |
| Wong, DT | 1 |
| Etchells, E | 1 |
| Higgins, P | 1 |
| Chung, F | 1 |
| Mathias, W | 1 |
| Tsutsui, JM | 1 |
| Andrade, JL | 1 |
| Kowatsch, I | 1 |
| Lemos, PA | 1 |
| Leal, SM | 1 |
| Khandheria, BK | 1 |
| Ramires, JF | 1 |
| Wikstrand, J | 1 |
| Berglund, G | 1 |
| Hedblad, B | 1 |
| Hulthe, J | 1 |
| Merritt, JC | 1 |
| Niebauer, M | 1 |
| Tarakji, K | 1 |
| Hammer, D | 1 |
| Mills, RM | 1 |
| Camsari, A | 1 |
| Arikan, S | 1 |
| Avan, C | 1 |
| Kaya, D | 1 |
| Pekdemir, H | 1 |
| Ciçek, D | 1 |
| Kiykim, A | 1 |
| Sezer, K | 1 |
| Akkuş, N | 1 |
| Alkan, M | 1 |
| Aydoğdu, S | 1 |
| Tabrizchi, R | 1 |
| Koepfli, P | 1 |
| Wyss, CA | 1 |
| Namdar, M | 1 |
| Klainguti, M | 1 |
| von Schulthess, GK | 1 |
| Lüscher, TF | 1 |
| Kaufmann, PA | 1 |
| Atar, I | 1 |
| Korkmaz, ME | 1 |
| Atar, IA | 1 |
| Gulmez, O | 1 |
| Ozin, B | 1 |
| Bozbas, H | 1 |
| Erol, T | 1 |
| Aydinalp, A | 1 |
| Yildirir, A | 1 |
| Yucel, M | 1 |
| Muderrisoglu, H | 1 |
| Jahnke, C | 1 |
| Paetsch, I | 1 |
| Achenbach, S | 1 |
| Schnackenburg, B | 1 |
| Gebker, R | 1 |
| Fleck, E | 1 |
| Nagel, E | 1 |
| Ioannidis, TI | 1 |
| Mazarakis, A | 1 |
| Notaras, SP | 1 |
| Karpeta, MZ | 1 |
| Tsintoni, AC | 1 |
| Kounis, GN | 1 |
| Rallis, DG | 1 |
| Kounis, NG | 1 |
| Yoganathan, T | 1 |
| Casthely, PA | 1 |
| Lamprou, M | 1 |
| Wolf, SC | 1 |
| Sauter, G | 1 |
| Jobst, J | 1 |
| Kempf, VA | 1 |
| Risler, T | 1 |
| Brehm, BR | 1 |
| Unverir, P | 1 |
| Topacoglu, H | 1 |
| Bozkurt, S | 1 |
| Kaynak, F | 1 |
| Leineweber, K | 1 |
| Bogedain, P | 1 |
| Wolf, C | 1 |
| Wagner, S | 1 |
| Weber, M | 1 |
| Jakob, HG | 1 |
| Heusch, G | 1 |
| Philipp, T | 1 |
| Brodde, OE | 1 |
| Fox, K | 1 |
| Borer, JS | 1 |
| Camm, AJ | 1 |
| Danchin, N | 1 |
| Ferrari, R | 1 |
| Lopez Sendon, JL | 1 |
| Steg, PG | 1 |
| Tardif, JC | 1 |
| Tavazzi, L | 1 |
| Tendera, M | 1 |
| Held, C | 1 |
| Eriksson, SV | 1 |
| Kuster, GM | 1 |
| Amann, FW | 1 |
| Neuenschwander, C | 1 |
| Drexel, H | 1 |
| Sjöblom, L | 1 |
| Eklund, A | 1 |
| Ostlund-Lindqvist, AM | 1 |
| Jönsson, L | 1 |
| Tijssen, JG | 1 |
| Simoons, ML | 1 |
| de Feijter, PJ | 1 |
| Hugenholtz, PG | 1 |
| Lubsen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Selective and Nonselective Beta-blockade on Platelet Aggregation in Patients With Acute Coronary Syndrome[NCT02809820] | Phase 4 | 100 participants (Actual) | Interventional | 2016-05-31 | Completed | ||
| Heart Rate Controller in Computed Tomography Coronary Angiography: A Randomized Controlled Trial of Metoprolol, Diltiazem and Ivabradine[NCT05261464] | Phase 4 | 246 participants (Anticipated) | Interventional | 2021-01-30 | Recruiting | ||
| A Single Centre, Retrospective Cohort Study on Post Analysis on the Link Between the Clinical Heart Rate and Outcomes During PCI[NCT02351674] | 15,000 participants (Anticipated) | Observational | 2015-01-31 | Not yet recruiting | |||
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for metoprolol and Coronary Artery Disease
| Article | Year |
|---|---|
Ivabradine and metoprolol in fixed dose combination: When, why and how to use it.
Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; Coronary Artery Disease; Drug Combinati | 2019 |
Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting.
Topics: Adrenergic alpha-1 Receptor Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbazoles; Ca | 2014 |
Should beta-blockers form the cornerstone for the treatment of congestive heart failure?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Dose | 2003 |
Resting heart rate in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca | 2007 |
Resting heart rate in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca | 2007 |
Resting heart rate in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca | 2007 |
Resting heart rate in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca | 2007 |
Nifedipine and metoprolol in suspected unstable angina. Unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Clinical T | 1987 |
18 trials available for metoprolol and Coronary Artery Disease
| Article | Year |
|---|---|
Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Coronary Artery Disease; | 2022 |
Topics: Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Computed Tomography Angiography | 2022 |
Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapy.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers | 2014 |
Nebivolol compared with metoprolol for erectile function in males undergoing coronary artery bypass graft.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Coronary Artery Bypass; Coro | 2016 |
[Effect of pathway training on rest heart rate and the application of β-blocker in coronary heart disease patients: an open-label, multi-center, prospective study].
Topics: Adrenergic beta-Antagonists; Beijing; Coronary Artery Disease; Heart Rate; Hospitalization; Humans; | 2015 |
[Effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease undergoing non-cardiac surgery].
Topics: Aged; Cardiovascular Diseases; Coronary Artery Disease; Female; Humans; Male; Metoprolol; Myocardial | 2008 |
Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Coron | 2009 |
The role of nebivolol in the prevention of contrast-induced nephropathy in patients with renal dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Benzopyrans; Contrast Media; Coronary Angiography; Coronary Artery D | 2011 |
Ivabradine versus metoprolol for heart rate reduction before coronary computed tomography angiography.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Benzazepines; Coronary Angiography; Co | 2012 |
Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Angina, Stable; Atenolol; Blood Pressure; Coron | 2012 |
Safety and efficacy of oral ivabradine as a heart rate-reducing agent in patients undergoing CT coronary angiography.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzazepines; Blood Pr | 2012 |
Successful implementation of perioperative beta-blockade utilizing a multidisciplinary approach.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anesthesia Recovery Period; Coronary Artery Di | 2003 |
Antiatherosclerotic effects of beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carotid Arteries; Coronary Artery Disease; | 2003 |
Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segments.
Topics: Adrenergic beta-Antagonists; Ammonia; Carbazoles; Carbon Isotopes; Carvedilol; Coronary Artery Disea | 2004 |
Effects of metoprolol therapy on cardiac troponin-I levels after elective percutaneous coronary interventions.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Blood Pressure; C | 2006 |
Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris.
Topics: Aged; Angina Pectoris; Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Coronary Artery | 2001 |
High density-lipoprotein subfractions of patients using cardio-selective beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Apolipoproteins; Atenolol; Cholesterol; Cholesterol, HDL; | 2002 |
Nifedipine and metoprolol in suspected unstable angina. Unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Clinical T | 1987 |
22 other studies available for metoprolol and Coronary Artery Disease
| Article | Year |
|---|---|
Speeding up beta-blockade prior to coronary CT angiography: can we predict the dose of intravenous metoprolol required to achieve target heart rate in a given patient?
Topics: Adrenergic beta-1 Receptor Antagonists; Computed Tomography Angiography; Coronary Angiography; Coron | 2021 |
Safety, Efficacy, and Dose Protocol of Metoprolol for Heart Rate Reduction in Pediatric Outpatients Undergoing Cardiac CT Angiography.
Topics: Adolescent; Child; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; H | 2021 |
Influence of Different β-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aspirin; Bisoprolol; Carbazoles; Carvedilol; Clopidog | 2016 |
Prognostic value of SYNTAX score based on coronary computed tomography angiography.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Coronary Angiography; Coronary Artery Disease; Female; | 2015 |
The effect of metoprolol on perioperative outcome in coronary patients undergoing nonvascular abdominal surgery.
Topics: Adrenergic beta-Antagonists; Case-Control Studies; Cause of Death; Coronary Artery Disease; Digestiv | 2008 |
In-stent late total occlusion following left main coronary artery stenting.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; A | 2008 |
Effects of metoprolol and diltiazem on plasma homocysteine levels in patients with isolated coronary artery ectasia.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Artery Disease; Dilatation, Patholog | 2009 |
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carb | 2009 |
Questionable benefit of perioperative beta-blockade.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Coronary Artery Disease; Data Interpretation, | 2009 |
Multiple coronary-cameral fistulae causing angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Echocar | 2009 |
Impact of β(1)- and β(2)-adrenergic receptor gene single nucleotide polymorphisms on heart rate response to metoprolol prior to coronary computed tomographic angiography.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Coronary Angiography; Coronary Artery D | 2013 |
Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment.
Topics: Adrenergic beta-Antagonists; Chromatography, High Pressure Liquid; Cohort Studies; Coronary Artery D | 2002 |
Value of rapid beta-blocker injection at peak dobutamine-atropine stress echocardiography for detection of coronary artery disease.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atropine; Coronary Artery Disease; Echoca | 2003 |
Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Carbazoles; Carvedilol; Coronary | 2003 |
Metoprolol, a beta-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Aged; Blood Pressure; Coronary | 2003 |
Coronary MR imaging: breath-hold capability and patterns, coronary artery rest periods, and beta-blocker use.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Coronary Vesse | 2006 |
Hymenoptera sting-induced Kounis syndrome: effects of aspirin and beta-blocker administration.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Animals; Anti-Inflammatory Agents, Non-Steroidal | 2007 |
Dantrolene-induced hyperkalemia in a patient treated with diltiazem and metoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Corona | 1988 |
Major differences in gene expression in human coronary smooth muscle cells after nebivolol or metoprolol treatment.
Topics: Adrenergic beta-Antagonists; Benzopyrans; Cell Proliferation; Coronary Artery Disease; Coronary Vess | 2008 |
Cardiovascular toxicity due to metoprolol poisoning in a patient with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Electrocardiog | 2007 |
In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-adrenoceptor polymorphism.
Topics: Adrenergic beta-Antagonists; Aged; Arginine; Blood Pressure; Cardiac Output; Cardiopulmonary Bypass; | 2007 |
Effects of diet and metoprolol on lipid levels in the blood plasma and morphology of the heart and intramural branches of coronary arteries of spontaneously hypertensive male rats. A 9-month study.
Topics: Animals; Aorta; Caseins; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Coronary Artery Disease; | 1989 |